Articles
NANS Launches New Website at NANS.org
The North American Neuromodulation Society (NANS) is excited to announce the launch of its newly…
NANS Transitions to a Calendar-Based Membership Renewal Cycle
Beginning September 1, 2026, the North American Neuromodulation Society (NANS) will transition from an anniversary-based membership…
CMS Issues Proposed 2027 Medicare Physician Fee Schedule
On July 14, 2026, the Centers for Medicare & Medicaid Services (CMS) released the Calendar…
Applications Open for the NANS/ION Early Stage Investigator Research Grant
The North American Neuromodulation Society (NANS) and the Institute of Neuromodulation (ION) are investing in…
NANS Strengthens Its Voice in National Health Policy
NANS participated in the 2026 American Medical Association (AMA) House of Delegates Annual Meeting, held…
NANS Publishes New Curriculum for Deep Brain Stimulation (DBS) Training
The North American Neuromodulation Society (NANS) has published a new consensus curriculum for deep brain stimulation (DBS) implantation training.
NANS Urges UnitedHealthcare to Revisit Stroke Therapy Coverage
The North American Neuromodulation Society (NANS) is calling on UnitedHealthcare (UHC) to reconsider its policy denying coverage for implantable vagus nerve stimulation (iVNS) paired with rehabilitation for stroke recovery.
NANS Joins Coalition Urging Action on No Surprises Act Implementation
The North American Neuromodulation Society (NANS) has joined more than 100 medical organizations in a joint letter to federal agencies raising concerns about how the No Surprises Act (NSA) is being implemented.
NANS, Medical Societies Urge Elevance Health to Reconsider PNS Coverage
The North American Neuromodulation Society (NANS), alongside several leading medical societies, recently submitted a joint…
NANS Joins Multisociety Advocacy on Trigger Point Injection Policy
NANS joined a coalition of leading medical societies in submitting formal comment letters to First Coast Service Options and Novitas regarding the proposed LCD for trigger point injections (TPIs).
NANS Applauds Aetna for Revising Policy on Peripheral Electrical Nerve Stimulation for Pain Policy
The North American Neuromodulation Society (NANS) recognizes Aetna for updating its clinical policy on peripheral electrical nerve stimulation (PNS) for pain, expanding access to non-pharmacological treatment options for patients with chronic pain.
NANS Opens Public Comment on Draft PNS Guideline
The North American Neuromodulation Society (NANS) has opened the public comment period for its draft Clinical Guideline on Implantable Peripheral Nerve Stimulation (PNS) for Chronic Pain—one of the first formal guideline initiatives undertaken by the Society.